278 related articles for article (PubMed ID: 18583921)
1. PAF, rather than histamine, participates in mouse anaphylactic hypotension.
Shibamoto T; Liu W; Cui S; Zhang W; Takano H; Kurata Y
Pharmacology; 2008; 82(2):114-20. PubMed ID: 18583921
[TBL] [Abstract][Full Text] [Related]
2. Mouse anaphylactic shock is caused by reduced cardiac output, but not by systemic vasodilatation or pulmonary vasoconstriction, via PAF and histamine.
Wang M; Shibamoto T; Tanida M; Kuda Y; Kurata Y
Life Sci; 2014 Oct; 116(2):98-105. PubMed ID: 25252221
[TBL] [Abstract][Full Text] [Related]
3. Hepatic microvascular pressure during anaphylactic shock in anesthetized rats.
Takano H; Shibamoto T; Zhang W; Kurata Y; Toga H
Microvasc Res; 2009 Sep; 78(2):169-73. PubMed ID: 19573539
[TBL] [Abstract][Full Text] [Related]
4. Characterization of cardiovascular events mediated by platelet activating factor during systemic anaphylaxis.
Felix SB; Baumann G; Hashemi T; Niemczyk M; Ahmad Z; Berdel WE
J Cardiovasc Pharmacol; 1990 Jun; 15(6):987-97. PubMed ID: 1694923
[TBL] [Abstract][Full Text] [Related]
5. Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731.
Doebber TW; Wu MS; Biftu T
J Immunol; 1986 Jun; 136(12):4659-68. PubMed ID: 3011900
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models.
Nagaoka J; Harada K; Kimura A; Kobayashi S; Murakami M; Yoshimura T; Yamada K; Asano O; Katayama K; Yamatsu I
Arzneimittelforschung; 1991 Jul; 41(7):719-24. PubMed ID: 1663352
[TBL] [Abstract][Full Text] [Related]
7. Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions.
Arias K; Baig M; Colangelo M; Chu D; Walker T; Goncharova S; Coyle A; Vadas P; Waserman S; Jordana M
J Allergy Clin Immunol; 2009 Aug; 124(2):307-14, 314.e1-2. PubMed ID: 19409603
[TBL] [Abstract][Full Text] [Related]
8. Head-down tilt posture attenuates anaphylactic hypotension in mice and rats.
Zhao Z; Shibamoto T; Cui S; Takano H; Zhang W; Kurata Y
J Physiol Sci; 2007 Oct; 57(5):269-74. PubMed ID: 17875232
[TBL] [Abstract][Full Text] [Related]
9. Venous resistance increases during rat anaphylactic shock.
Cui S; Shibamoto T; Zhang W; Takano H; Kurata Y
Shock; 2008 Jun; 29(6):733-9. PubMed ID: 17998891
[TBL] [Abstract][Full Text] [Related]
10. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
Toth PD; Mikulaschek AW
Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423
[TBL] [Abstract][Full Text] [Related]
11. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.
Terashita Z; Imura Y; Takatani M; Tsushima S; Nishikawa K
J Pharmacol Exp Ther; 1987 Jul; 242(1):263-8. PubMed ID: 3612533
[TBL] [Abstract][Full Text] [Related]
12. The responses of pulmonary and systemic circulation and airway to anaphylactic mediators in anesthetized BALB/c mice.
Wang M; Shibamoto T; Kuda Y; Tanida M; Zhang T; Song J; Kurata Y
Life Sci; 2016 Feb; 147():77-84. PubMed ID: 26808090
[TBL] [Abstract][Full Text] [Related]
13. Hepatic pre-sinusoidal vessels contract in anaphylactic hypotension in rabbits.
Karasawa N; Shibamoto T; Cui S; Takano H; Kurata Y; Tsuchida H
Acta Physiol (Oxf); 2007 Jan; 189(1):15-22. PubMed ID: 17280553
[TBL] [Abstract][Full Text] [Related]
14. Combined H1 and H2 receptor blockade attenuates the cardiovascular effects of high-dose atracurium for rapid sequence endotracheal intubation.
Hosking MP; Lennon RL; Gronert GA
Anesth Analg; 1988 Nov; 67(11):1089-92. PubMed ID: 2461127
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor acts on cortisol secretion by perfused guinea-pig adrenals via calcium-/phospholipid-dependent mechanisms.
Shimada T; Hirose T; Matsumoto I; Aikawa T
J Endocrinol; 2005 Feb; 184(2):381-91. PubMed ID: 15684346
[TBL] [Abstract][Full Text] [Related]
16. Activation of human mast cells through the platelet-activating factor receptor.
Kajiwara N; Sasaki T; Bradding P; Cruse G; Sagara H; Ohmori K; Saito H; Ra C; Okayama Y
J Allergy Clin Immunol; 2010 May; 125(5):1137-1145.e6. PubMed ID: 20392487
[TBL] [Abstract][Full Text] [Related]
17. Anaphylactic reaction induced by Toxoplasma gondii-derived heat shock protein 70.
Fang H; Aosai F; Mun HS; Norose K; Ahmed AK; Furuya M; Yano A
Int Immunol; 2006 Oct; 18(10):1487-97. PubMed ID: 16943259
[TBL] [Abstract][Full Text] [Related]
18. Effects of 1-[3-(4-benzhydryl-1-piperazinyl)propyl]-3- (1H-imidazol-1-ylmethyl)-1H-indole-6-carboxylic acid with thromboxane A2 synthetase inhibitory and H1-blocking activities on anaphylactic bronchospasm.
Nakamura S; Shirahase H; Kanda M; Wada K; Kamiya S; Matsui H; Kurahashi K
Arzneimittelforschung; 1996 Nov; 46(11):1067-71. PubMed ID: 8955866
[TBL] [Abstract][Full Text] [Related]
19. Involvement of splanchnic vascular bed in anaphylactic hypotension in anesthetized BALB/c mice.
Liu W; Takano H; Shibamoto T; Cui S; Zhao ZS; Zhang W; Kurata Y
Am J Physiol Regul Integr Comp Physiol; 2007 Nov; 293(5):R1947-53. PubMed ID: 17715178
[TBL] [Abstract][Full Text] [Related]
20. High dose of lipopolysaccharide pre-treatment prevents OVA-induced anaphylactic decreases in rectal temperature in the immunized mice.
Shiva D; Matsumoto T; Kremenik MJ; Kato Y; Yano H
Immunol Lett; 2008 Jun; 118(1):59-64. PubMed ID: 18433880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
